Agf Investments LLC Bristol Myers Squibb CO Transaction History

Agf Investments LLC

$1.09 Billion
Q3 2022

A detailed history of Agf Investments LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Agf Investments LLC holds 23,897 shares of BMY stock, worth $1.22 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

23,897

Previous 12,261 94.9%

Holding current value

$1.22 Million

Previous $944,000 79.98%

% of portfolio

0.16%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $1,512 - $894,110	11,636 Added 94.9%	23,897 $1.7 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $33,332 - $36,710	-459 Reduced 3.61%	12,261 $944,000
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $246,104 - $295,101	-4,003 Reduced 23.94%	12,720 $929,000
Q4 2021 Feb 01, 2022	BUY	$53.63 - $62.52 $745,403 - $868,965	13,899 Added 492.17%	16,723 $1.04 Million
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $10,118 - $11,852	-171 Reduced 5.71%	2,824 $167,000
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $61 - $67	1 Added 0.03%	2,995 $200,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $118,917 - $133,746	-2,004 Reduced 40.1%	2,994 $189,000
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $12,818 - $14,525	-222 Reduced 4.25%	4,998 $310,000
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $1.45 Million - $1.61 Million	-25,324 Reduced 82.91%	5,220 $315,000
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $743,578 - $869,316	-13,564 Reduced 30.75%	30,544 $1.8 Million
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $204,160 - $296,692	-4,400 Reduced 9.07%	44,108 $2.46 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $1.86 Million - $2.43 Million	37,830 Added 354.28%	48,508 $3.11 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $132,373 - $156,947	3,095 Added 40.81%	10,678 $541,000
Q2 2019 Jul 30, 2019	BUY	$44.62 - $49.34 $174,687 - $193,166	3,915 Added 106.73%	7,583 $344,000
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $3.29 Million - $3.93 Million	-72,978 Reduced 95.21%	3,668 $175,000
Q4 2018 Feb 08, 2019	BUY	$48.76 - $63.23 $193,382 - $250,770	3,966 Added 5.46%	76,646 $3.98 Million
Q3 2018 Nov 09, 2018	BUY	$55.19 - $62.25 $4.01 Million - $4.52 Million	72,680 New	72,680 $4.51 Million
Q3 2018 Nov 07, 2018	SELL	$55.19 - $62.25 $3.32 Million - $3.74 Million	-60,111 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $263,463 - $328,377	-5,214 Reduced 7.98%	60,111 $3.33 Million
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $686,383 - $790,165	-11,455 Reduced 14.92%	65,325 $4.13 Million
Q4 2017 Feb 07, 2018	BUY	$59.94 - $65.35 $870,328 - $948,881	14,520 Added 23.32%	76,780 $4.71 Million
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $3.44 Million - $3.97 Million	62,260	62,260 $3.97 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.

Account

Agf Investments LLC Bristol Myers Squibb CO Transaction History